Avalo Therapeutics Inc. (AVTX)

AI Score

Unlock

5.85

-0.74 (-11.23%)

At close: Apr 04, 2025, 3:59 PM

6.09

4.02%

After-hours: Apr 04, 2025, 05:45 PM EDT

Avalo Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	134.55M	7.42M	13.17M	54.59M	18.92M	3.61M	10.65M	2.47M	5.13M	21.16M	11.74M	3.42M	9.52M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	7.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	131K	227K	148.64K	101.94K	81.72K	131.35K	62.83K	n/a	n/a	n/a	n/a
Other Long-Term Assets	131K	131K	131K	1.23M	149K	102K	-91.24K	131.35K	173.00	n/a	117.17K	873.85K	-56.75K
Receivables	611K	136K	1.92M	4.8M	2.18M	n/a	822.33K	2.94M	132.47K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	20K	38K	3K	21K	1.11M	382.15K	11K	n/a	n/a	n/a	n/a
Other Current Assets	3.73M	844K	1.3M	51K	2.25M	1.2M	9.41M	4.18M	11.11K	58.83K	58.33K	n/a	429.96K
Total Current Assets	138.89M	8.39M	16.42M	61.84M	26M	17.72M	21.93M	10.99M	5.66M	21.62M	12.16M	4.14M	9.95M
Property-Plant & Equipment	1.21M	1.97M	2.41M	2.69M	1.61M	1.45M	586.51K	44.61K	43K	35K	38.74K	65.99K	56.75K
Goodwill & Intangibles	10.5M	10.5M	14.41M	14.45M	15.99M	16.84M	47.65M	31.96M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.84M	12.6M	16.95M	18.37M	17.75M	18.39M	48.32M	32.13M	106K	35K	155.91K	939.84K	56.75K
Total Assets	150.73M	20.99M	33.37M	80.21M	43.76M	36.11M	70.25M	43.12M	5.77M	21.66M	12.32M	5.08M	10.02M
Account Payables	283K	446K	2.88M	3.37M	2.57M	2.08M	1.45M	1.3M	1.01M	678.11K	931.14K	1.64M	821.11K
Deferred Revenue	n/a	n/a	88K	16.02M	10.88M	-155.81K	2.03M	n/a	942.57K	1.89M	975.11K	n/a	n/a
Short-Term Debt	n/a	n/a	5.93M	n/a	n/a	n/a	n/a	n/a	2.35M	3.21M	1.91M	n/a	n/a
Other Current Liabilities	6.11M	3.06M	9.98M	1.74M	3.36M	9.93M	21.14M	8.71M	675.39K	835.56K	1.18M	431.58K	722.68K
Total Current Liabilities	6.96M	4.62M	22.11M	19.89M	15.22M	12.16M	26.22M	11.41M	4.31M	5.85M	4.99M	3.07M	1.54M
Long-Term Debt	n/a	n/a	13.49M	32.83M	n/a	n/a	n/a	n/a	n/a	2.35M	5.31M	n/a	n/a
Other Long-Term Liabilities	10.47M	8.92M	8.54M	4.3M	3.97M	1.76M	23.06M	3.85M	1.25M	370.54K	28.35M	19.86M	n/a
Total Long-Term Liabilities	10.74M	9.07M	22.17M	37.24M	3.97M	2.95M	23.13M	3.86M	1.25M	8.57M	33.65M	19.86M	n/a
Total Liabilities	17.7M	13.69M	44.28M	57.13M	19.19M	15.11M	49.34M	15.26M	5.56M	8.57M	38.65M	22.92M	1.54M
Total Debt	568K	537K	19.42M	32.83M	426.35K	1.27M	15.38M	n/a	2.35M	5.56M	7.21M	n/a	n/a
Common Stock	10K	1K	9K	113K	75K	44K	40.8K	2.69M	9.43K	8.65K	650.00	643.00	18K
Retained Earnings	-370.26M	-335.13M	-303.82M	-262.17M	-177.79M	-114.29M	-98.22M	-58.17M	-70.04M	-53.56M	-43.07M	-27.02M	-13.97M
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	-0.00	n/a	2.66M	n/a	-21.66B	-28.35M	-19.86M	n/a
Shareholders Equity	133.03M	7.3M	-10.91M	23.08M	24.56M	21M	20.91M	27.86M	207K	13.08M	-26.33M	-17.85M	8.48M
Total Investments	n/a	131K	131K	227K	148.64K	7.63M	81.72K	131.35K	62.83K	n/a	n/a	n/a	n/a